Effect of recombinant erythropoietin in covid-19 patients.
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: J22- Unspecified acute lower respiratory infection
- Registration Number
- CTRI/2020/11/028959
- Lead Sponsor
- All India Institute Of Medical Sciences New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
sars-cov-2 positive patients.
moderate to severe disease who require non-invasive or invasive ventilation.
Exclusion Criteria
patients relative refusal.
terminal end-organ failure (renal, liver, cardiac, cns)
thrombocytosis.
concomitant potential serious infections.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Deescalation from mechanical ventilation and mortality benefit.Timepoint: 02 weeks
- Secondary Outcome Measures
Name Time Method Improvement in clinical status, length of icu and hospital stay, sero-conversion rate,Timepoint: 02 weeks